ENDPOINTS

Amgen plans more gradual MariTide dosing in Phase 3 

Amgen plans on using a lower starting dose for its long-acting obesity shot MariTide in Phase 3 than it did in Phase 2 in an effort to mitigate gastrointestinal side effects, mid-stage results showed on ...

Jun 23, 2025 - 21:30
 0
Amgen plans more gradual MariTide dosing in Phase 3 
Amgen plans on using a lower starting dose for its long-acting obesity shot MariTide in Phase 3 than it did in Phase 2 in an effort to mitigate gastrointestinal side effects, mid-stage results showed on ...
Read More

Tags:

Previous Article

Politics collide with science ahead of new ACIP meeting

Next Article

Maestro's Star Wars Duel Of The Fates Arrives Alongside PlayStation VR2 Release

Related Posts

FDA places hold on Gilead's studies of HIV treatment pill combo

FDA places hold on Gilead's studies of HIV treatment pi...

Jun 10, 2025  0

Vera posts positive Phase 3 rare kidney disease data, but crowded market looms

Vera posts positive Phase 3 rare kidney disease data, b...

Jun 2, 2025  0

Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B

Sanofi to snap up Blueprint Medicines and mastocytosis ...

Jun 2, 2025  0